Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

1-deoxynojirimycin-hydroxychalcone heterozygote derivative and preparation method and application thereof

A technology of deoxynojirimycin and hydroxychalcone, which is applied in the field of medicine and food, can solve the problems of mediocre effect and hindering the decomposition of disaccharides, and achieve the effect of lowering postprandial blood sugar and good application prospects

Active Publication Date: 2019-03-12
JIANGXI AGRICULTURAL UNIVERSITY
View PDF10 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

1-Deoxynojirimycin (1-DNJ) is an imino sugar that has been studied more at present. It has a chemical structure similar to glucose, and its affinity with α-glucosidase is greater than that of disaccharides, which can hinder the synthesis of disaccharides. Decomposed, it is a powerful competitive α-glucosidase inhibitor, but the substance is absorbed quickly in the body and is metabolized quickly, so the effect of inhibiting the rise of blood sugar after meals in the body is general

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • 1-deoxynojirimycin-hydroxychalcone heterozygote derivative and preparation method and application thereof
  • 1-deoxynojirimycin-hydroxychalcone heterozygote derivative and preparation method and application thereof
  • 1-deoxynojirimycin-hydroxychalcone heterozygote derivative and preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0039] Example 1: Preparation of 1-deoxynojirimycin-hydroxychalcone hybrid derivative (DC-2)

[0040] (1) Preparation of intermediates of hydroxychalcones connected to the bridge:

[0041] Add 2g (13.5mmol) 2'-hydroxychalcone and 7.62g (40.5mmol) 1,2-dibromoethane raw materials into a 100mL round bottom flask, then add 3.7g (27mmol) potassium carbonate and 50mL acetone, Stir and react at 65°C until the end of the reaction; after the end of the reaction, pour the above reaction solution into water, extract with 20 mL of ethyl acetate, repeat the extraction 3 times, combine the organic phases; dry with anhydrous sodium sulfate , then desolvation and mixing of the sample, separation by silica gel column chromatography, the eluent is sherwood oil / ethyl acetate=20:1, and the middle of the hydroxychalcone that has inserted the connecting bridge of 2 carbon atoms is obtained. body; 1 HNMR (500MHz, DMSO) δ7.77(d, J=3.6Hz, 1H), 7.76(d, J=2.2Hz, 1H), 7.61(d, J=3.7Hz, 2H), 7.58(dd, J= ...

Embodiment 2

[0044] Example 2: Preparation of 1-deoxynojirimycin-hydroxychalcone hybrid derivative (DC-5)

[0045] (1) Preparation of intermediates of hydroxychalcones connected to the bridge:

[0046] Add 2g (13.5mmol) 2'-hydroxychalcone and 9.31g (40.5mmol) 1,5-dibromopentane raw materials into a 100mL round bottom flask, then add 3.7g (27mmol) potassium carbonate and 50mL acetone, Stir and react at 65°C until the end of the reaction; after the end of the reaction, pour the above reaction solution into water, extract with 20 mL of ethyl acetate, repeat the extraction 3 times, combine the organic phases; dry with anhydrous sodium sulfate , and then precipitate and mix the sample, adopt silica gel column chromatography to separate, the eluent is sherwood oil / ethyl acetate=20:1, and the intermediate of the hydroxychalcone that has inserted the connecting bridge of 5 carbon atoms is obtained body. 1 HNMR (500MHz, DMSO) δ7.78–7.63(m,2H), 7.52(dd,J=14.1,6.3Hz,4H),7.47–7.39(m,3H),7.16(d,J=8.5...

Embodiment 3

[0049] Example 3: Preparation of 1-deoxynojirimycin-hydroxychalcone hybrid derivative (DC-3)

[0050] (1) Preparation of intermediates of hydroxychalcones connected to the bridge:

[0051] Add 2g (13.5mmol) 2'-hydroxychalcone and 8.18g (40.5mmol) 1,3-dibromopropane raw materials into a 100mL round bottom flask, then add 3.7g (27mmol) potassium carbonate and 50mL acetone, Stir and react at 65°C until the end of the reaction; after the end of the reaction, pour the above reaction solution into water, extract with 20 mL of ethyl acetate, repeat the extraction 3 times, and combine the organic phases; dry with anhydrous sodium sulfate, Then desolventize and mix the sample, and use silica gel column chromatography to separate, the eluent is sherwood oil / ethyl acetate=20:1, and the intermediate of hydroxychalcone with a connecting bridge of 3 carbon atoms is obtained ; 1 HNMR(500MHz,DMSO)δ7.74(d,J=3.7Hz,1H),7.73–7.72(m,1H),7.56–7.51(m,3H),7.46(s,1H),7.45–7.42(m ,3H),7.20(d,J=8.2Hz...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the fields of medicines and food, in particular to a 1-deoxynojirimycin-hydroxychalcone heterozygote derivative and a preparation method and application thereof. The 1-deoxynojirimycin-hydroxychalcone heterozygote derivative is of a structure as shown in the formula (I), in-vitro tests prove that the compound is a powerful alpha-glucosidase inhibitor, and the alpha-glucosidase inhibiting activity is significantly higher than that of a postprandial blood sugar control agent acarbose which is most commonly used currently, wherein the activity of DC-5 and DC-2 is significantly higher than that of 1-deoxynojirimycin. Due to the fact that the compound can powerfully inhibit activity of sugar digestive enzymes of alpha-glucosidase and the like, and can effectively reducepostprandial blood sugar, so that the compound has excellent application prospects in hypoglycemic medicines and auxiliary hypoglycemic food.

Description

technical field [0001] The invention relates to the fields of medicine and food, in particular to a 1-deoxynojirimycin-hydroxychalcone hybrid derivative and a preparation method and application thereof. Background technique [0002] According to the statistics of the International Diabetes Federation (IDF), in 2013 there were about 382 million diabetic patients in the world, and 316 million people with impaired glucose tolerance, which cost 548 billion U.S. dollars in medical expenses each year, accounting for 11% of the total medical expenses; about 5,000 in my country million diabetics, ranking second in the world; in recent years, due to changes in eating habits, lifestyles and the environment, hyperglycemia and diabetes patients continue to increase, showing an accelerated upward trend. Hyperglycemia, diabetes and their complications have seriously damaged people's health, greatly reduced their quality of life, and at the same time caused a heavy economic burden to famili...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D211/46A61K31/445A61P3/10A23L7/104A23L5/10A23L33/00
CPCA23L5/13A23L7/104A23L33/00A23V2002/00A61P3/10C07D211/46A23V2200/328
Inventor 尹忠平彭大勇上官新晨陈继光吴少福林萍曾凡新
Owner JIANGXI AGRICULTURAL UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com